Neurogene Inc.
NGNE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404644
In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Neurogene Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −5 vs. Q2 2023
- Shares held
- 3.65M
- +192.5K (+5.6%) vs. Q2 2023Converted for a 1-for-5 split
- Total value
- $14.4M
- +$72.2K (+0.5%) vs. Q2 2023
- New holders
- 5
- 7 more added
- Sold out
- 10
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NGNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $544.4M |
| Q1 2026 | 96 | $342.0M |
| Q4 2025 | 93 | $340.4M |
| Q3 2025 | 88 | $265.2M |
| Q2 2025 | 83 | $230.1M |
| Q1 2025 | 86 | $192.8M |
| Q4 2024 | 89 | $367.8M |
| Q3 2024 | 86 | $581.1M |
| Q2 2024 | 66 | $482.7M |
| Q1 2024 | 60 | $617.3M |
| Q4 2023 | 35 | $179.0M |
| Q3 2023 | 31 | $14.4M |
| Q2 2023 | 36 | $14.3M |
| Q1 2023 | 39 | $10.5M |
| Q4 2022 | 46 | $8.66M |
| Q3 2022 | 52 | $12.0M |
| Q2 2022 | 64 | $21.4M |
| Q1 2022 | 81 | $46.3M |
| Q4 2021 | 80 | $118.8M |
| Q3 2021 | 85 | $187.1M |
| Q2 2021 | 82 | $248.8M |
| Q1 2021 | 82 | $341.9M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Neurogene Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| National Bank of Canada | 35 | $134 | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| JPMorgan Chase & Co | 45 | $178 | 0.00% | +0+0.9% | AddedConverted for a 1-for-5 split |
| Advisor Group Holdings, Inc. | 100 | $395 | 0.00% | −200−66.7% | ReducedConverted for a 1-for-5 split |
| Truvestments Capital LLC | 185 | $731 | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| Farther Finance Advisors, LLC | 200 | $790 | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| UBS Group AG | 231 | $912 | 0.00% | +11+5.0% | AddedConverted for a 1-for-5 split |
| Group One Trading, L.P. | 299 | $1.18K | 0.00% | −2−0.6% | ReducedConverted for a 1-for-5 split |
| Tower Research Capital LLC (TRC) | 823 | $3.25K | 0.00% | +823 | New |
| Wells Fargo & Company | 1,653 | $6.53K | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| Susquehanna International Group, LLP | 13,154 | $52.0K | 0.00% | +13,154 | New |
| Northern Trust Corp | 13,727 | $54.2K | 0.00% | −181−1.3% | ReducedConverted for a 1-for-5 split |
| US Bancorp | 13,869 | $54.8K | 0.00% | +5,000+56.4% | AddedConverted for a 1-for-5 split |
| Citadel Advisors LLC | 21,961 | $86.7K | 0.00% | +12,383+129.3% | AddedConverted for a 1-for-5 split |
| Kynam Capital Management, LP | 24,037 | $94.9K | 0.02% | 00.0% | UnchangedConverted for a 1-for-5 split |
| State Street Corp | 24,510 | $96.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| CVI Holdings, LLC | 24,916 | $98.4K | 0.20% | +24,916 | New |
| Point72 Asset Management, L.P. | 27,335 | $108.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| Two Sigma Advisers, LP | 33,880 | $133.8K | 0.00% | −3,020−8.2% | ReducedConverted for a 1-for-5 split |
| Two Sigma Investments, LP | 34,206 | $135.1K | 0.00% | −8,033−19.0% | ReducedConverted for a 1-for-5 split |
| Millennium Management LLC | 37,756 | $149.1K | 0.00% | −84,174−69.0% | ReducedConverted for a 1-for-5 split |
| Geode Capital Management, LLC | 62,885 | $248.5K | 0.00% | +2,674+4.4% | AddedConverted for a 1-for-5 split |
| BlackRock Inc. | 96,613 | $381.6K | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| BML Capital Management, LLC | 98,664 | $389.7K | 0.36% | +93,914+1,977.2% | AddedConverted for a 1-for-5 split |
| Morgan Stanley | 107,671 | $425.3K | 0.00% | −56,723−34.5% | ReducedConverted for a 1-for-5 split |
| Renaissance Technologies LLC | 163,447 | $646.0K | 0.00% | −23,998−12.8% | ReducedConverted for a 1-for-5 split |
| Vanguard Group Inc | 201,539 | $796.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| Bank of America Corp | 231,779 | $915.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-5 split |
| Nantahala Capital Management, LLC | 299,999 | $1.18M | 0.15% | +299,999 | New |
| Adage Capital Partners GP, L.L.C. | 310,000 | $1.22M | 0.00% | +310,000 | New |
| Redmile Group, LLC | 582,443 | $2.30M | 0.11% | 00.0% | UnchangedConverted for a 1-for-5 split |
| Baker Bros. Advisors LP | 1,221,414 | $4.82M | 0.03% | +457,066+59.8% | AddedConverted for a 1-for-5 split |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −618,911−100.0% | Sold outConverted for a 1-for-5 split |
| Western Standard LLC | 0 | $0 | 0.00% | −172,176−100.0% | Sold outConverted for a 1-for-5 split |
| Privium Fund Management (UK) Ltd | 0 | $0 | 0.00% | −23,440−100.0% | Sold outConverted for a 1-for-5 split |
| Alta Fundamental Advisers LLC | 0 | $0 | 0.00% | −17,940−100.0% | Sold outConverted for a 1-for-5 split |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −9,682−100.0% | Sold outConverted for a 1-for-5 split |
| Simon Quick Advisors, LLC | 0 | $0 | 0.00% | −4,686−100.0% | Sold outConverted for a 1-for-5 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −2,874−100.0% | Sold outConverted for a 1-for-5 split |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −311−100.0% | Sold outConverted for a 1-for-5 split |
| Barclays PLC | 0 | $0 | 0.00% | −33−100.0% | Sold outConverted for a 1-for-5 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −118−100.0% | Sold outConverted for a 1-for-5 split |